重磅!“每个县至少1个公立中医院”,2018全国中医药工作会议部署五大重点任务

2018-01-16 佚名 中国中医药报

1月15日,2018年全国中医药工作会议在北京召开。会议回顾总结2017年中医药工作和党的十八大以来中医药取得的成就,并研究部署2018年重点任务。

1月15日,2018年全国中医药工作会议在北京召开。会议回顾总结2017年中医药工作和党的十八大以来中医药取得的成就,并研究部署2018年重点任务。

党中央、国务院对开好这次会议高度重视。国务院总理李克强专门作出重要批示,充分肯定党的十八大以来中医药系统围绕促进中医药发展、提升中医药服务能力等做了大量扎实有效的工作,勉励中医药工作者在新的一年要全面深入贯彻党的十九大精神,以习近平新时代中国特色社会主义思想为指导,认真落实全国卫生与健康大会部署,坚持中西医并重,充分发挥中医药独特优势,传承中医药宝库精髓,进一步完善中医药服务体系,积极应用现代化技术大力发展中医药,推动在重大疾病防治、重大新药创制、重大技术攻关等方面取得突破,大力培养中医药人才,推动中医药发展升级,助力脱贫攻坚和乡村振兴,为建设健康中国、保障人民健康作出更大贡献。

国务院副总理刘延东也对会议作出重要批示,高度肯定党的十八大以来中医药系统凝心聚力、开拓进取,推动中医药战略地位显着提升,法治建设取得突破性进展,服务能力、传承创新、国际影响长足进步,振兴发展迈出坚实步伐。勉励中医药工作者要深入调查研究,坚持问题导向,坚定不移深化中医药改革,力争在发挥中医药“三个作用”、推进“四个建立健全”、激发和释放中医药“五种资源”潜力和活力上有更大作为,传承发展祖国医学财富,努力实现创造性转化、创新性发展。

李克强总理和刘延东副总理的重要批示,为做好当前和今后一个时期的中医药工作指明了方向、提供了遵循。国家卫生计生委主任、党组书记李斌出席会议并讲话。

国家卫生计生委副主任、国家中医药管理局局长王国强作了题为《全面贯彻落实党的十九大精神,奋力开创新时代中医药工作新局面》的工作报告。

报告指出,2017年中医药振兴发展迈出坚实的一大步。

一是以实施“一法一纲要”为重点,贯彻中央决策部署更加有力。

二是以推进深化医改中医药工作为关键,中医药服务能力更加突显。

三是以促进融合发展为突破,中医药健康服务供给更加多元。

四是以提升科技创新能力为支撑,创新驱动发展的成效更加明显。

五是以人才队伍建设为基础,人才脱颖而出的局面更加生动。

六是以服务“一带一路”建设为导向,中医药“走出去”的步伐更加稳健。

七是以迎接学习贯彻党的十九大精神为主线,推进全面从严治党更加有力。

报告总结了十八大以来中医药事业取得的历史性成就,中医药战略地位跃上新高度,中医药法治建设实现新跨越,中医药服务能力有了新提升,中医药科技创新取得新突破,中医药人才队伍建设呈现新局面,中医药文化发展迈上新台阶,中医药海外发展书写新篇章,全面从严治党焕发新气象。

这五年,是党中央高度重视、政策密集出台、实践创新发展的五年,是深度融入大局、全面深化改革、持续激发活力的五年,是发展提速加力、能力大幅提升、优势不断彰显的五年,是人民获得感和行业自豪感显着增强的五年,是中医药发展极不平凡的五年。

报告要求,深入学习贯彻习近平新时代中国特色社会主义思想和党的十九大精神,准确把握新时代中医药工作的新任务新要求,扎实落实好今年中医药工作的重点任务。

第一,在学懂弄通做实上下功夫,进一步把学习贯彻习近平新时代中国特色社会主义思想和党的十九大精神引向深入。

第二,在持续统筹推进上下功夫,进一步贯彻实施中医药法和中医药发展战略规划纲要。

第三,在激发发展活力上下功夫,进一步深化中医药改革。包括要纵深推进深化医改中医药工作;要深化中医药科技体制改革;要促进中医药健康服务发展;要深化中医药人才发展机制改革;要推进中医药文化创造性转化、创新性发展;要健全中医药“走出去”行稳致远的机制。

其中,在“要纵深推进深化医改中医药工作”中,提出:

“要促进中医药健康服务发展”中则提出深化“放管服”改革,优化中医药服务供给,提高服务质量和水平。

促进中医药与养老、旅游、食品、体育、互联网融合发展,深化国家中医药健康旅游示范区、示范基地、示范项目建设,建设一批中医药特色医养结合示范基地,引导社会办中医连锁化、规模化发展。

第四,在“建高地、筑网底、拓空间、促协调”上下功夫,进一步提升中医药的发展质量和水平。

第五,在加强党的政治建设上下功夫,进一步推进全面从严治党。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
    2018-01-18 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
    2018-01-18 xxxx1054
  5. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1957525, encodeId=a89f195e52580, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Sat Mar 03 21:55:00 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409287, encodeId=f161140928e12, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490634, encodeId=927a14906341c, content=<a href='/topic/show?id=a9f421596b7' target=_blank style='color:#2F92EE;'>#中医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21596, encryptionId=a9f421596b7, topicName=中医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c38798346, createdName=nakerunner, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549272, encodeId=6e2c15492e2ea, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624000, encodeId=c99c16240005d, content=<a href='/topic/show?id=ebf7958e8e5' target=_blank style='color:#2F92EE;'>#重点任务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95878, encryptionId=ebf7958e8e5, topicName=重点任务)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96920636931, createdName=vividelife, createdTime=Thu Jan 18 00:55:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=279033, encodeId=e5362e9033ef, content=宏扬祖国医学.发展中医., beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 16 09:59:36 CST 2018, time=2018-01-16, status=1, ipAttribution=)]
    2018-01-16 1e0f8808m18(暂无匿称)

    宏扬祖国医学.发展中医.

    0